Bingran Yu

机构：Children's Hospital of Fudan University, Beijing University of Chemical Technology

发表论文 25 篇 · 总被引 72 次 · h-index 5

代表论文

• Targeting the NOTCH2/ADAM10/TCF7L2 Axis‐Mediated Transcriptional Regulation of Wnt Pathway Suppresses Tumor Growth and Enhances Chemosensitivity in Colorectal Cancer (2024 · Advanced Science · 被引 22)
• Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma (2023 · Journal of Hepatocellular Carcinoma · 被引 16)
• Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma (2023 · Journal of Hepatocellular Carcinoma · 被引 14)
• Comparison of clinicopathologic characteristics among patients with HBV-positive, HCV-positive and Non-B Non-C hepatocellular carcinoma after hepatectomy: a systematic review and meta-analysis (2023 · BMC Gastroenterology · 被引 6)
• A gene mutation-based risk model for prognostic prediction in liver metastases (2023 · BMC Genomics · 被引 4)
• Prognostic impact of body composition in hepatocellular carcinoma patients undergoing interventional and systemic therapy (2025 · Frontiers in Nutrition · 被引 2)